Delivery Order SPE2DR25D9312-SPE2DR26FGET6
- Not listed
- The Defense Logistics Agency awarded a $29,925 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Fasenra Pen 30 mg/ml. This firm fixed-price delivery order, issued on January 13, 2026, with an ultimate completion date of January 14, 2026, was awarded without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The contract...
- The Defense Logistics Agency awarded a delivery order valued at $2,493.75 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Fasenra Pen 30 mg/mL. This firm fixed-price delivery order, issued on January 20, 2026, with an ultimate completion date of January 21, 2026, was awarded without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement....
- The Defense Logistics Agency issued a delivery order valued at $2,493.75 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for Fasenra pen 30 mg/ml. The award, dated January 27, 2026, is firm fixed-price with an ultimate completion date of January 28, 2026, and carries no set-aside designation. DMS Pharmaceutical Group will perform at its Park Ridge facility. This delivery order represents a routine pharmaceutical...
- The Defense Logistics Agency awarded a $7,481.25 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for Fasenra Pen 30 mg/ml. The award, issued on January 20, 2026, with an ultimate completion date of January 21, 2026, carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's single-award...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,493.75 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Fasenra Pen 30 mg/mL. The award, issued on January 5, 2026, with an ultimate completion date of January 6, 2026, utilizes firm fixed-price pricing with no set-aside designation, indicating the vendor competed in unrestricted federal procurement. DMS Pharmaceutical Group...
- The Defense Logistics Agency awarded a delivery order valued at $2,493.75 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Fasenra Pen 30mg/ml. The award, issued on January 14, 2026, with an ultimate completion date of February 11, 2026, utilizes firm fixed-price pricing with no set-aside designation. DMS Pharmaceutical Group will perform the delivery from its Park Ridge facility, leveraging its...
- The Defense Logistics Agency awarded a delivery order valued at $2,493.75 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Fasenra Pen 30 mg/ml. The delivery order, issued on January 9, 2026, with an ultimate completion date of January 12, 2026, operates under a firm fixed-price contract structure with no set-aside designation. DMS Pharmaceutical Group is performing work at its headquarters location in...
- The Defense Logistics Agency awarded a $2,493.75 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for Fasenra Pen 30 mg/mL. This delivery order, issued on January 20, 2026, with an ultimate completion date of January 21, 2026, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award was funded by the Defense Logistics...
- The Defense Logistics Agency issued a delivery order valued at $14,962.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of FASENRA PEN 30 MG/ML. This firm fixed-price delivery order, awarded on January 5, 2026, with an ultimate completion date of January 6, 2026, was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award...
- The Defense Logistics Agency awarded a $24,937.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Fasenra Pen 30 mg/ml. The delivery order, issued on January 14, 2026, with an ultimate completion date of January 15, 2026, carries no set-aside designation, demonstrating the vendor's competitive capability in unrestricted federal procurement. This award was executed...
- SPE2DR25D9312Indefinite Delivery Contract
- SPE2DR25D9312-SPE2DR26FGET6Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $12,468.75 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Fasenra Pen 30 mg/ml. This firm fixed-price delivery order, issued on January 28, 2026, with an ultimate completion date of January 29, 2026, was made without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award falls under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy that authorizes DLA to issue delivery orders for comprehensive pharmaceutical products and medical consumables supporting Department of Defense healthcare operations globally. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, with the PPV-G GEN V prime vendor contract—awarded on November 13, 2025, with a $499,999,999 ceiling value and completion date of December 31, 2036—positioning the company to serve military healthcare facilities worldwide. The company's extensive product portfolio encompasses branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables, with demonstrated performance across numerous delivery orders issued by the Defense Logistics Agency's Medical Supply Chain division. No subcontractor relationships were identified in the award documentation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.5k | 1/27/26 |